(Q30498461)

11 August 2017

1 reference

title

Biomarkers for the effects of antipsychotic drugs in healthy volunteers (English)

1 reference

11 August 2017

0 references

S J de Visser

1

1 reference

11 August 2017

J van der Post

2

1 reference

11 August 2017

M S Pieters

3

1 reference

11 August 2017

A F Cohen

4

1 reference

11 August 2017

J M van Gerven

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

51

1 reference

11 August 2017

119-132

1 reference

11 August 2017

2

1 reference

Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Hyperprolactinaemia induced by risperidone.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Single oral dose kinetics of zotepine and its relationship to prolactin response and side effects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Psychiatry. More choices for treating voices

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Correlation of auditory 'oddball' P300 with verbal memory deficits in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Multilead quantitative EEG profile of clozapine in resting and vigilance-controlled conditions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Neuropsychological and P300 abnormalities in schizophrenics and their relatives.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

On dopaminergic modulation of temporal information processing.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

ERP abnormalities during semantic processing in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Single dose human pharmacology of umespirone

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Psychomotor impairment and cognitive disturbances induced by neuroleptics.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Brain potential evidence for an auditory sensory memory deficit in schizophrenia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Selected quantitative EEG (QEEG) and event-related potential (ERP) variables as discriminators for positive and negative schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Dopamine autoreceptor stimulation: Clinical significance

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Benzodiazepines impair smooth pursuit eye movements

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

The action of sedatives on brain stem oculomotor systems in man

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Hormonal probes of central serotonergic activity: do they really exist?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effect of haloperidol on a symbol digit substitution task in normal adult males

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Is there a common dopaminergic basis of time perception and reaction time?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Haloperidol and cognitive shifting

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effects of remoxipride on psychomotor performance, alone and in combination with ethanol and diazepam.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

P300 in first degree relatives of schizophrenics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A selective review of biological markers in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A phase-overlapping anhedonia-model (animal-volunteer-patient) to predict the effects of neuroleptics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

The effect of neuroleptics on cognitive and psychomotor function. A preliminary study in healthy volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.

20 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

The effects of chlorpromazine and lorazepam on abnormal antisaccade and no-saccade distractibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

The effects of sulpiride on psychomotor performance and subjective tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

The cerebral cortex: a case for a common site of action of antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

P300 subcomponents reflect different aspects of psychopathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Dopamine receptors, antipsychotic action and schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjects

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Intravenous administration of haloperidol to healthy volunteers: lack of subjective effects but clear objective effects.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A cognitive-neuroscience approach for elucidation of mechanisms underlying temporal information processing.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

A comparison of some psychological and physiological effects exerted by zetidoline (DL308) and by oxazepam

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

Neuroendocrine effects of setoperone: a new neuroleptic drug.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014436

26 November 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

The use of analogue scales in rating subjective feelings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Effects of temazepam on saccadic eye movements: concentration-effect relationships in individual volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Suppression of HPA-axis activity by haloperidol after experimentally induced heat stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Olanzapine: interaction study with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Effect of sulpiride on vigilance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Thioridazine dose-related effects on biomechanical force platform measures of sway in young and old men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2001.01308.X

Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations

21 January 2018

1 reference

12 December 2020

The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol

1 reference

12 December 2020

The effects of remoxipride and chlorpromazine on eye movements and psychomotor performance in healthy volunteers

1 reference

12 December 2020

Effects of the dopamine-related drug bromocriptine on event-related potentials and its relation to the law of initial value

1 reference

12 December 2020

Effect of fenfluramine on episodic ACTH and cortisol secretion

1 reference

12 December 2020

Haloperidol enhances latent inhibition in visual tasks in healthy people

1 reference

12 December 2020

Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests

1 reference

12 December 2020

Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers

1 reference

12 December 2020

Dopaminergic and serotoninergic influence on duration discrimination and vigilance

1 reference

12 December 2020

Influence of rate of administration of raclopride on akathisia and prolactin response

1 reference

12 December 2020

Effect of the dopamine receptor blocking agent pimozide on the growth hormone response to arginine and exercise and on the spontaneous growth hormone fluctuations

1 reference

12 December 2020

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans

1 reference

12 December 2020

Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers

1 reference

12 December 2020

Spontaneous motor activity in healthy volunteers after single doses of haloperidol

1 reference

12 December 2020

Neuroendocrine Tests during Treatment with Neuroleptic Drugs. I. Plasma Prolactin Response to Haloperidol Challenge

1 reference

12 December 2020

Remoxipride versus haloperidol in healthy volunteers: psychometric performance and subjective tolerance profiles

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II

1 reference

12 December 2020

Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I

1 reference

12 December 2020

A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers

1 reference

12 December 2020

The new selective D2-dopamine receptor antagonist raclopride--pharmacokinetics, safety and tolerability in healthy males

1 reference

12 December 2020

Guidelines for the use of antipsychotic drug studies in healthy volunteers. The BAP Consensus Group

1 reference

12 December 2020

Effects of remoxipride on measures of psychological performance in healthy volunteers

1 reference

12 December 2020

10.1111/J.1365-2125.2001.01308.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference